Episode
Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- Published
- May 26, 2026
- Duration seconds
- 1797
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/genitourinary-cancers-5-minute-journal-club-issue-1-with-professor-thomas-powles-current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/genitourinary-cancers-5-minute-journal-club-issue-1-with-professor-thomas-powles-current-and-future-role-of-tumor-informed-circulating-tumor-dna-assays.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer. CME information and select publications here .